Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-25 @ 9:46 PM
Study NCT ID:
NCT00698451
Status:
COMPLETED
Last Update Posted:
2013-09-06
First Post:
2008-06-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2010-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-12
First Submit QC Date:
None
Study First Post Date:
2008-06-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-12-10
Results First Submit QC Date:
None
Results First Post Date:
2013-07-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-08-20
Last Update Post Date:
2013-09-06
Last Update Post Date Type:
ESTIMATED